The results revealed that pretreatment with the Nrf2 inhibitor or the HO-1 inhibitor abolished the cognitive improvement induced by Apelin-13, suggesting that the Nrf2-HO-1 pathway may play a crucial role in mediating the behavioral effects of Apelin-13 in AD mice. This evidence concerns the gene APLN and Alzheimer disease.